FEMY · Femasys Inc · Metrics
Market Cap
$9.70M
Shares
8.66M
Volume · Nov 17
110.56K
Avg daily vol (3M)
695.5K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
FEMY metrics
68 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$1.12
Market cap
$9.70M
Price action
23 metricsPrice change (1W)
-21.7%
Price change (30D)
-31.3%
Price change (3M)
-49.1%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$20.20
52-week low
$1.12
Change from 52-week high
-94.5%
Change from 52-week low
+0.0%
Annualized volatility
103.4%
Annualized volatility (3M)
98.1%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.8
RSI (14D)
29.3
Price vs SMA 50
-40.8%
Price vs SMA 200
—
Avg volume (3M)
695,502
Relative volume
0.2
Average dollar volume
$1.83M
Company
3 metricsSector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
8.66M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.9×
reciprocal yield 20.4%
P / book
0.4
reciprocal yield 278.8%
FCF yield
-178.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-125.2%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2024-03-21
Profitability
9 metricsGross margin
59.9%
Operating margin
-929.9%
Trailing 12 months
Net margin
-614.7%
Gross profit (TTM)
$1.18M
Operating profit (TTM)
−$18.36M
Net income (TTM)
−$12.14M
Trailing 12 months
Diluted EPS (TTM)
$-1.43
FCF margin
-877.5%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-44.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.97M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+322.3%
Year over year · more shares
Revenue CAGR (3Y)
+23.9%
Revenue CAGR (5Y)
+17.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-44.9%
Return on assets
-34.6%
Debt / equity
—
Current ratio
8.7
EBITDA (TTM)
−$18.03M
Free cash flow (TTM)
−$17.33M
Quick ratio
7.0
Interest coverage
-18.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$23.91M
Latest balance sheet
Cash & equivalents
$23.91M
Total assets
$35.09M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$17.08M
Capital expenditures (TTM)
$245,890
R&D (TTM)
$7.01M
SG&A (TTM)
—
Stock compensation (TTM)
$619,067
R&D / revenue
355.1%
Stock compensation / revenue
31.3%
Ownership (13F)
9 metrics13F filers
28
13F filer change QoQ
+10
Institutional ownership
75.9%
Conviction holders (share of 13F filers)
3.6%
Crowding (high-turnover and private-fund holders)
65.8%
Private-fund adviser ownership
22.5%
Active holders' share change QoQ
+229.3%
Holder tenure
4.4
Price vs estimated holder cost
-31.5%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.7%
Short interest
3 metricsShort interest
0.6%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
33 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1339005
CUSIP
31447E204
13F (30d)
26 filings
26 filers
Visit website
Investor relations